Drug Shortage Report for AURO-ALENDRONATE

Last updated on 2021-02-18 History
Report ID 131191
Drug Identification Number 02388545
Brand name AURO-ALENDRONATE
Common or Proper name AURO PHARMA INC
Company Name AURO PHARMA INC
Market Status MARKETED
Active Ingredient(s) ALENDRONIC ACID
Strength(s) 10MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 100
ATC code M05BA
ATC description DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2021-01-05
Estimated end date 2021-03-31
Actual end date 2021-02-04
Shortage status Resolved
Updated date 2021-02-18
Company comments
Health Canada comments
Contact Address 3700 STEELES AVENUE WEST, SUITE 402
WOODBRIDGE, ONTARIO
CANADA L4L 8K8
Company contact information Balaji Srinivasan

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2021-02-18 French Compare
v6 2021-02-18 English Compare
v5 2021-02-12 French Compare
v4 2021-02-12 English Compare
v3 2021-01-19 English Compare
v2 2021-01-08 French Compare
v1 2021-01-08 English Compare